VulnTideExploited vulnerabilities, by vendor. Data as of .
Not in CISA KEVReported exploited: VulnCheck KEV since Published EPSS 0.6% probability of exploitation in 30 days

CVE-2022-42045: Certain Zemana products are vulnerable to Arbitrary code injection.

Is it exploited?

Reported, not confirmed by CISA. VulnCheck KEV lists it as exploited in the wild. CISA has not added it to its Known Exploited Vulnerabilities catalog as of .

VulnCheck KEV lists it since . It cites 1 public report, the first from .

How likely is exploitation in the next 30 days?
0.6%

EPSS score, percentile 46.3 of all scored records. A probability estimated by FIRST, not a report of exploitation.

How severe?
Not scored

The CVE record carries no CVSS score.

What should I do?

CISA has set no required action, because the vulnerability is not in KEV.

The CVE record links no vendor advisory, patch or mitigation.

Which versions are affected?

Not stated. The CVE record gives vendor and product as “n/a” and the version as “unspecified”.

Source: CISA KEV 2026.10.29, as of ; VulnCheck KEV, as of ; FIRST EPSS, as of ; CVE List, as of . About the data.

Description

Certain Zemana products are vulnerable to Arbitrary code injection. This affects Watchdog Anti-Malware 4.1.422 and Zemana AntiMalware 3.2.28.

Source: CVE List, as of . About the data.

What to do

Advisories and patches

The CVE record links no vendor advisory, patch or mitigation.

This summary is based on the CVE record as of . Check the vendor's advisory before you act: affected versions and fixes can change.

Affected products and versions

The CVE record does not name affected products or versions: vendor and product are “n/a” and the version is “unspecified”.

Source: CVE List, as of . About the data.

Weakness

CWE-94
  • CWE-94: Improper Control of Generation of Code ('Code Injection')

CWE and CAPEC are maintained by MITRE; the entries are those named in the CVE record.

Timeline

DateEvent
CVE record published
CVE record last updated

References

1